Larimar Therapeutics, Inc. — Investor Relations & Filings
Filings indexed
666
across all filing types
Latest filing
2026-05-19
Regulatory Filings
Country
US
United States of America
Listing
US
LRMR
Larimar Therapeutics, Inc. is a clinical-stage biotechnology company focused on developing treatments for complex rare diseases. The company utilizes a proprietary intracellular delivery platform to design fusion proteins that deliver therapeutic molecules to targets within cells. Its lead product candidate, nomlabofusp (formerly CTI-1601), is a recombinant fusion protein being evaluated in a Phase 2 clinical program for the treatment of Friedreich's ataxia, a rare and progressive genetic disease. Larimar Therapeutics plans to leverage its platform to develop additional therapies for other rare diseases characterized by deficiencies in intracellular proteins.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 8-K | 2026-05-19 | English | |
| 10-Q | 2026-05-14 | English | |
| 8-K | 2026-05-14 | English | |
| S-8 - Larimar Therapeutics, Inc. (0001374690) (Filer) | 2026-03-19 | English | |
| 10-K - Larimar Therapeutics, Inc. (0001374690) (Filer) | 2026-03-19 | English | |
| 8-K - Larimar Therapeutics, Inc. (0001374690) (Filer) | 2026-03-19 | English |
Browse filings by year
18 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 46557399 | 8-K | 2026-05-19 | English | ||
| 46282456 | 10-Q | 2026-05-14 | English | ||
| 45966119 | 8-K | 2026-05-14 | English | ||
| 32989784 | S-8 - Larimar Therapeutics, Inc. (0001374690) (Filer) | 2026-03-19 | English | ||
| 32989111 | 10-K - Larimar Therapeutics, Inc. (0001374690) (Filer) | 2026-03-19 | English | ||
| 32985493 | 8-K - Larimar Therapeutics, Inc. (0001374690) (Filer) | 2026-03-19 | English | ||
| 32890859 | 4 - LARIMAR THERAPEUTICS, INC. (0001374690) (Filer) | 2026-03-03 | English | ||
| 32890855 | 4 - LARIMAR THERAPEUTICS, INC. (0001374690) (Filer) | 2026-03-02 | English | ||
| 32890857 | 4 - LARIMAR THERAPEUTICS, INC. (0001374690) (Filer) | 2026-03-02 | English | ||
| 32890858 | 4 - LARIMAR THERAPEUTICS, INC. (0001374690) (Filer) | 2026-03-02 | English | ||
| 32890863 | 8-K - LARIMAR THERAPEUTICS, INC. (0001374690) (Filer) | 2026-02-26 | English | ||
| 32890866 | 8-K - LARIMAR THERAPEUTICS, INC. (0001374690) (Filer) | 2026-02-24 | English | ||
| 29193640 | SCHEDULE 13G/A Filing | 2026-02-12 | English | ||
| 29193648 | 4 Filing | 2026-01-27 | English | ||
| 29193643 | 4 Filing | 2026-01-27 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Cte Group Spolka Akcyjna
Diversified firm in HR services, corporate events, and comp…
|
LPS | PL | Professional, scientific and te… |
|
curacle co., ltd.
A clinical-stage biopharma developing drugs for intractable…
|
365270 | KR | Professional, scientific and te… |
|
CVR Medical Corp.
Med-tech developing non-invasive diagnostics using sound wa…
|
CRRVF | CA | Professional, scientific and te… |
|
CYNATA THERAPEUTICS LIMITED
Develops regenerative medicine therapies using iPSC-derived…
|
CYP | AU | Professional, scientific and te… |
|
CytoMed Therapeutics Ltd
Clinical-stage developer of off-the-shelf allogeneic cell i…
|
GDTC | SG | Professional, scientific and te… |
|
Cytophage Technologies Ltd.
Creates tailor-made synthetic phages to prevent and treat b…
|
CYTO | CA | Professional, scientific and te… |
|
Cyxone AB
A clinical-stage biotech developing therapies for autoimmun…
|
CYXO | SE | Professional, scientific and te… |
|
DARWIN AG
Biotechnology firm creating personalized products from indi…
|
7V0 | DE | Professional, scientific and te… |
|
DEINOVE
Develops compounds from rare bacteria for cosmetics and new…
|
ALDEI | FR | Professional, scientific and te… |
|
Delta Drone
Develops drone-based systems for the logistics, security, a…
|
ALDR | FR | Professional, scientific and te… |
Larimar Therapeutics, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/33359/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=33359 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=33359 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=33359 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 33359}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Larimar Therapeutics, Inc. (id: 33359)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.